2085. Evaluation of Panther Fusion Flu A/B/RSV, AdV/hMPV/RV and Paraflu Assays for the Detection of Respiratory Viruses in Children
Session: Poster Abstract Session: Diagnostics: Virology
Saturday, October 6, 2018
Room: S Poster Hall
Background: There are many FDA cleared multiplexed respiratory assays available in the USA, ranging from 3 to 20 targets per assay. FilmArray Respiratory Panel (RP) is one of the mega-multiplexed assay, includes 20 targets and results are available in 1 hr. Recently Hologic has received FDA-clearance for several smaller respiratory ‘Panther Fusion assays’ (3-4 targets/assay) and results are available in less than 3 hr. The aim of this study was to evaluate the performance of three Panther Fusion multiplexed assays; i) Flu A/B/RSV assay, ii) adenovirus/human metapneumovirus/rhinovirus assay, and iii) paraflu (parainfluenza virus 1-4) assay in comparison to RP assay.

Methods: A total of 194 frozen nasopharyngeal swab samples (from 2016-2018) obtained from children aged ≤18 years and previously tested by RP as a routine clinical testing were included in this study. These samples were tested by all three fusion assays. Positive percent agreement (PPA) and negative percent agreement (NPA) of Fusion assays were calculated against RP assay.

Results: Among 194 samples, 58.0% were from male. Median age was 36 months (IQR 13-72 months). Overall agreement between two assays was 82.5% (95% CI 77.6-88.1). PPA and NPA of Fusion assays for each target was; Flu A- 100.0% and 100.0%, Flu B-95.0% and 100.0%, RSV-90.1% and 94.0%, adenovirus- 80.0% and 98.2%, hMPV- 95.2% and 99.4%, Rhino-79.1% and 95.8%, Parainfluenza virus-100.0% and 100.0% respectively. There were total 34 discrepant samples. Among these, majority were rhino (n=12), RSV (n-12) and adenovirus (n=7). Of 12 rhinovirus discrepant samples, Fusion assay detected additional 7 but missed 5 samples. For 12 RSV discrepant samples, fusion assay detected 10 more RSV but missed 2. Fusion assay missed 4 adenovirus and detected additional 3 samples. All discrepant samples, especially rhinovirus positive samples need further investigation since RP detects both rhinovirus and enterovirus whereas the Fusion assay detects rhinovirus only.

Conclusion: Performance of Fusion Flu A/B/RSV and Paraflu assays were comparable with RP assays. Fusion AdV/hMPV/RV assay had the highest discrepancy with RP assay. Overall, Panther Fusion respiratory assays provide the opportunity to customize testing with smaller respiratory panels at a reduced cost.

Ferdaus Hassan, PhD, Jordan Crawford, BS, Dithi Banerjee, PhD and Rangaraj Selvarangan, PhD, Children's Mercy, Kansas City, MO

Disclosures:

F. Hassan, None

J. Crawford, None

D. Banerjee, None

R. Selvarangan, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.